Baillie Gifford — RXRX Trade History
Quarter-by-quarter changes in the Recursion Pharmaceuticals Inc position · CUSIP 75629V104
Currently held · 5.3 YearsFirst seen: 2021 Q2
| Quarter | Filed | Activity | Shares | Δ Shares | Δ % | Value | % Port. |
|---|---|---|---|---|---|---|---|
| 2026 Q2 | 2026-08-06 | Reduce | 23,487,907 | -187,500 | -0.8% | $86.2M | 0.08% |
| 2026 Q1 | 2026-05-08 | Reduce | 23,675,407 | -99,565 | -0.4% | $72.7M | 0.07% |
| 2025 Q4 | 2026-01-23 | Reduce | 23,774,972 | -203,723 | -0.8% | $97.2M | 0.08% |
| 2025 Q3 | 2025-10-31 | Reduce | 23,978,695 | -195,120 | -0.8% | $117.0M | 0.09% |
| 2025 Q2 | 2025-08-06 | Reduce | 24,173,815 | -219,200 | -0.9% | $122.3M | 0.09% |
| 2025 Q1 | 2025-05-07 | Reduce | 24,393,015 | -471,043 | -1.9% | $129.0M | 0.11% |
| 2024 Q4 | 2025-01-31 | Reduce | 24,864,058 | -375,812 | -1.5% | $168.1M | 0.13% |
| 2024 Q3 | 2024-11-05 | Reduce | 25,239,870 | -1,350,066 | -5.1% | $166.3M | 0.12% |
| 2024 Q2 | 2024-07-25 | Add | 26,589,936 | 2,522,132 | +10.5% | $199.4M | 0.15% |
| 2024 Q1 | 2024-05-01 | Reduce | 24,067,804 | -111,700 | -0.5% | $240.0M | 0.19% |
| 2023 Q4 | 2024-01-26 | Reduce | 24,179,504 | -371,905 | -1.5% | $238.4M | 0.19% |
| 2023 Q3 | 2023-11-13 | Reduce | 24,551,409 | -546,221 | -2.2% | $187.8M | 0.17% |
| 2023 Q2 | 2023-07-28 | Reduce | 25,097,630 | -37,900 | -0.2% | $187.5M | 0.16% |
| 2023 Q1 | 2023-05-03 | Add | 25,135,530 | 314,680 | +1.3% | $167.7M | 0.15% |
| 2022 Q4 | 2023-03-10 | Add | 24,820,850 | 3,226,157 | +14.9% | $191.4M | 0.20% |
| 2022 Q3 | 2022-10-27 | Reduce | 21,594,693 | -10,992 | -0.1% | $229.8M | 0.24% |
| 2022 Q2 | 2022-08-08 | Reduce | 21,605,685 | -375,919 | -1.7% | $175.9M | 0.18% |
| 2022 Q1 | 2022-05-05 | Reduce | 21,981,604 | -141,551 | -0.6% | $157.4M | 0.11% |
| 2021 Q4 | 2022-01-20 | Add | 22,123,155 | 61,781 | +0.3% | $379.0M | 0.21% |
| 2021 Q3 | 2021-10-19 | Add | 22,061,374 | 3,540,374 | +19.1% | $507.6M | 0.27% |
| 2021 Q2 | 2021-08-02 | New | 18,521,000 | 18,521,000 | — | $676.0M | 0.33% |
| 2021 Q1 | 2021-05-06 | — | — | — | — | — | — |
| 2020 Q4 | 2021-02-10 | — | — | — | — | — | — |
| 2020 Q3 | 2020-11-12 | — | — | — | — | — | — |
| 2020 Q2 | 2020-08-12 | — | — | — | — | — | — |
| 2020 Q1 | 2020-05-08 | — | — | — | — | — | — |
| 2019 Q4 | 2020-02-10 | — | — | — | — | — | — |
| 2019 Q3 | 2019-11-07 | — | — | — | — | — | — |
| 2019 Q2 | 2019-08-08 | — | — | — | — | — | — |
| 2019 Q1 | 2019-05-01 | — | — | — | — | — | — |
| 2018 Q4 | 2019-02-14 | — | — | — | — | — | — |
| 2018 Q3 | 2018-11-13 | — | — | — | — | — | — |
| 2018 Q2 | 2018-07-17 | — | — | — | — | — | — |
| 2018 Q1 | 2018-05-10 | — | — | — | — | — | — |
| 2017 Q4 | 2018-02-13 | — | — | — | — | — | — |
| 2017 Q3 | 2017-10-20 | — | — | — | — | — | — |
| 2017 Q2 | 2017-08-10 | — | — | — | — | — | — |
| 2017 Q1 | 2017-05-12 | — | — | — | — | — | — |
| 2016 Q4 | 2017-02-14 | — | — | — | — | — | — |
| 2016 Q3 | 2016-11-09 | — | — | — | — | — | — |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.